March 27, 2023 — Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces cardiovascular deaths, strokes, and other adverse outcomes by 20% compared to usual care.

March 24, 2023 — Abbott announced new data that found monitoring patients remotely with hemodynamic pressure sensing technology, such as with its CardioMEMS HF System, can significantly1 improve survival in heart failure patients with reduced ejection fraction (HFrEF).

March 24, 2023 — The American College of Surgeons (ACS), with the Society for Vascular Surgery (SVS), has launched a new national quality verification program to help participating hospitals improve outcomes and deliver the best treatment for patients receiving vascular surgical and interventional care in an inpatient setting. 

March 24, 2023 — Vaxxinity, Inc., a Cape Canaveral, FL-based company pioneering the development of a new class of immunotherapeutic vaccines, has announced that the first subjects have been dosed in a randomized, double-blind, placebo-controlled Phase 1 clinical trial of VXX-401.

AiMed Summit 2023

The 2023 AiMed Global Summit will focus on artificial intelligence (AI) in healthcare, and will offer valuable insights into the latest use cases, perspectives and novel approaches in healthcare AI. The event is scheduled to take place June 4-7 at the San Diego Convention Center in San Diego, Calif.

March 23, 2023 — Newly-published research has debunked the idea that there is an “obesity paradox,” whereby patients with heart failure who are overweight or obese are thought to be less likely to end up in hospital or die than people of normal weight.

March 22, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its algorithm intended to detect suspected abdominal aortic aneurysm (AAA). Viz AAA is the first FDA-cleared AI-powered solution for the detection and triage of suspected AAA. 

March 22, 2023 — Brainomix, the AI-powered medtech solutions company, today announced that its Brainomix 360 e-ASPECTS tool for stroke has received FDA clearance, enabling the Oxford-based company to deploy its cutting-edge stroke AI imaging platform to US stroke centers.  

March 22, 2023 — Windtree Therapeutics, Inc., a biotechnology company focused on advancing multiple late-stage interventions for cardiovascular disorders, announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now